Literature DB >> 12631538

Scleroderma and solvent exposure among women.

David H Garabrant1, James V Lacey, Timothy J Laing, Brenda W Gillespie, Maureen D Mayes, Brenda C Cooper, David Schottenfeld.   

Abstract

Exposure to solvents has been reported to increase the risk of scleroderma. The authors investigated the relation between exposures to solvents in occupational and hobby settings and the development of scleroderma among women in a case-control study with population-based controls in Michigan (1980-1991) and Ohio (1980-1992). A total of 660 cases and 2,227 frequency-matched controls were interviewed by telephone. Diagnoses of scleroderma were verified by medical records review. Paint thinners and removers were significantly associated with scleroderma both by self-report (odds ratio (OR) = 1.9, 95% confidence interval (CI): 1.4, 2.6) and after expert review (OR = 2.0, 95% CI: 1.5, 2.6). Other petroleum distillates (gasoline and mineral spirits) were not significantly associated with scleroderma after controlling for other correlated exposures in multivariable analyses. Trichloroethylene was associated with scleroderma both by self-report (OR = 2.0, 95% CI: 0.8, 4.8) and after expert review (OR = 1.9, 95% CI: 0.6, 6.6), but not significantly. Analyses by duration of exposure found that risk increased with the duration of use of any of the solvents (OR = 1.01/year of exposure, 95% CI: 1.01, 1.02), but there was no evidence of increasing risk with increasing duration of exposure for any specific solvent studied. In summary, exposures to paint thinners and removers were associated with scleroderma in women but showed no evidence of increasing risk with increasing duration. Exposures to other specific chlorinated and nonchlorinated hydrocarbon solvents were not clearly associated with scleroderma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631538     DOI: 10.1093/aje/kwf223

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

Review 1.  Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.

Authors:  Frederick W Miller; Lars Alfredsson; Karen H Costenbader; Diane L Kamen; Lorene M Nelson; Jill M Norris; Anneclaire J De Roos
Journal:  J Autoimmun       Date:  2012-06-25       Impact factor: 7.094

2.  Enhancing the Nrf2 Antioxidant Signaling Provides Protection Against Trichloroethene-mediated Inflammation and Autoimmune Response.

Authors:  Nivedita Banerjee; Hui Wang; Gangduo Wang; M Firoze Khan
Journal:  Toxicol Sci       Date:  2020-05-01       Impact factor: 4.849

Review 3.  Environmental risk factors of systemic sclerosis.

Authors:  Isabelle Marie; Jean-François Gehanno
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

4.  Contribution of job-exposure matrices for exposure assessment in occupational safety and health monitoring systems: application from the French national occupational disease surveillance and prevention network.

Authors:  Arnaud Florentin; Denis Zmirou-Navier; Christophe Paris
Journal:  Int Arch Occup Environ Health       Date:  2017-03-16       Impact factor: 3.015

Review 5.  Occupational and environmental scleroderma. Systematic review and meta-analysis.

Authors:  Manuel Rubio-Rivas; Rafael Moreno; Xavier Corbella
Journal:  Clin Rheumatol       Date:  2017-01-14       Impact factor: 2.980

6.  Was Paul Klee's scleroderma an occupational disease? A series of historical and clinical vignettes, part III.

Authors:  Richard M Silver
Journal:  J Scleroderma Relat Disord       Date:  2020-03-16

7.  Is exposure to environmental factors associated with a characteristic clinical and laboratory profile in systemic sclerosis? A retrospective analysis.

Authors:  Lisbeth A Aguila; Henrique Carriço da Silva; Ana Cristina Medeiros-Ribeiro; Bruna Giusto Bunjes; Ana Paula Luppino-Assad; Percival D Sampaio-Barros
Journal:  Rheumatol Int       Date:  2020-08-30       Impact factor: 2.631

8.  Apoptosis modulation as a promising target for treatment of systemic sclerosis.

Authors:  Stéphane Chabaud; Véronique J Moulin
Journal:  Int J Rheumatol       Date:  2011-09-06

9.  Role of MicroRNAs in Fibrosis.

Authors:  Serena Vettori; Steffen Gay; Oliver Distler
Journal:  Open Rheumatol J       Date:  2012-06-15

Review 10.  Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans.

Authors:  Glinda S Cooper; Susan L Makris; Paul J Nietert; Jennifer Jinot
Journal:  Environ Health Perspect       Date:  2009-01-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.